Medexprim, a leading European innovator in the field of Real-World Data and healthcare solutions, is pleased to announce its participation in the upcoming Radiological Society of North America (RSNA) from November 26 to 30, 2023, in Chicago.

Leveraging its unique capability to extract, normalize, and interoperate diverse imaging data along with associated clinical data, Medexprim provides high-quality, regulatory-grade multi-imaging datasets encompassing Clinical data, Genomics, Radiology, Radiotherapy, Digital Pathology, and Nuclear Medicine, empowering researchers, pharmaceutical companies, AI entities, and Medtech to unlock valuable insights for enhanced decision-making.

“We’re thrilled to join RSNA to unveil our unique expertise in multi-imaging: radiology, radiotherapy, nuclear medicine, and digital pathology. We’re covering the full spectrum of imaging data for the patient treatment journey, designed to address all pathologies reliant on imaging data, from Radiology to Genomics. This allows for an efficient treatment pipeline, streamlining patient care. We aim to help the transition from clinical research to routine care to create a virtuous circle ensuring that cutting-edge advances become an everyday reality in healthcare”, says Romain Cazavan, CEO of Medexprim.

Demos will be given throughout the RSNA on the Medexprim booth #4365.

For further details and to schedule a meeting with Medexprim at the event, please visit Meet Us | Medexprim.

About Medexprim
European leader in imaging & clinical data extraction, Medexprim bridges leading hospitals and pharmaceutical companies. Real-World data specialist, we help hospitals drive their research strategy and valorize their data. We provide our partners with secure access to multimodal, multicentric datasets for clinical research projects in oncology, cardiology, neurology, and rare diseases. We aim to structure the Real-World clinical and imaging data ecosystem in Europe to accelerate precision medicine.

Website – Linkedin
Press contact: Anne-Sophie Labeta – aslabeta@medexprim.com